FLSM
SRRA

Frazier Life Sciences Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Frazier Life Sciences Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-870,636
Closed -$47.9M – 47
2022
Q2 		$47.9M Sell
870,636
-1,471,562
-63% -$80.9M 4.52% 8
2022
Q1 		$75.1M Buy
+2,342,198
New +$75.1M 6.4% 4